Coronaviruses
The World's First International Journal Dedicated to Coronaviruses
Volume 2, 12 Issues, 2021
ISSN: 2666-7975 (Online)
ISSN: 2666-7967 (Print)
This journal supports open access
Volume 2, 12 Issues, 2021
ISSN: 2666-7975 (Online)
ISSN: 2666-7967 (Print)
This journal supports open access
Aims & Scope
Coronaviruses publishes original research articles, letters, reviews/mini-reviews, clinical trial and guest edited thematic issues on all aspects of coronaviruses such as their origins, types, transmission, pathogenesis, epidemiological, demographic, clinical and genomic characteristics etc.
The Journal also covers case reports and studies on outbreak of coronaviruses, their symptoms, related diseases, prevention, treatment and development of new therapeutics.
Coronaviruses
,Volume 2
-Number 2
Letter to the Editor Open Access
The Effects of Coronavirus (COVID-19) on the Psychological Health of Indian Poultry Farmers
Letter to the Editor Open Access
The COVID-19 and Munchausen Syndrome
, 2(2): 133 - 134Yadollah Abolfathi Momtaz*
DOI: 10.2174/2666796701999200818152652
The COVID-19 and Munchausen Syndrome
HIGHLIGHTS
Potential Mitigation, Prophylactics, and Treatments to Overcome COVID- 19
, 2(2): 135 - 137Prabagaran Narayanasamy*
DOI: 10.2174/2666796701999200921094712
Potential Mitigation, Prophylactics, and Treatments to Overcome COVID- 19
Opinion Article
COVID-19: An Opinion of Prevention and Dietary Based Management Hypothesis
, 2(2): 138 - 141Ashraf Talaat Youssef*
DOI: 10.2174/2666796701999200623172916
COVID-19: An Opinion of Prevention and Dietary Based Management Hypothesis
Review Article
SARS-CoV-2 Therapy: Old Drugs as New Interventions
, 2(2): 142 - 150Puneet K. Samaiya* and Mahendra Kumar
DOI: 10.2174/2666796701999200721003212
SARS-CoV-2 Therapy: Old Drugs as New Interventions
Review Article
Symptoms, Transmission, Prevention and Treatment of Pandemic Corona Virus: A Review
, 2(2): 151 - 158Tinsae Kebede, Dharmendra Kumar* and Pramod Kumar Sharma
DOI: 10.2174/2666796701999200713191436
Symptoms, Transmission, Prevention and Treatment of Pandemic Corona Virus: A Review
Review Article
Vaccine Development Against SARS-CoV-2: From Virology to Vaccine Clinical Trials
, 2(2): 159 - 171Kimia Kardani* and Azam Bolhassani
DOI: 10.2174/2666796701999201026205553
Vaccine Development Against SARS-CoV-2: From Virology to Vaccine Clinical Trials
Review Article
COVID-19: The Unprecedented Malady- A Holistic Review
, 2(2): 172 - 181Viney Chawla and Pooja A. Chawla*
DOI: 10.2174/2666796701999200813191218
COVID-19: The Unprecedented Malady- A Holistic Review
Coronaviruses, Volume 2 (2021) - Number 4
This issue is in progress but contains articles that are final and fully citable.
Coronaviruses, Volume 2 (2021) - Number 3
This issue is in progress but contains articles that are final and fully citable.
Articles Ahead of Print
Diagnosis and Possible use of Traditional Medicinal Plant to combat COVID-19
M. Beyau Konyak, Richa Naredi, Ekta Rana and Ramendra Pati Pandey*
DOI: 10.2174/2666796702666210127111351
View Abstract
Major Drugs Used in COVID-19 Treatment: Molecular Mechanisms, Validation and Current Progress in Trials
Md. Asaduzzaman Khan*, Shad Bin Islam, Mejbah Uddin Rakib, Didarul Alam, Md. Munnaf Hossen, Mousumi Tania and Asaduzzaman Asad
DOI: 10.2174/2666796701999201204122819
View Abstract
Study of SARS-nCoV2 Indian Isolates Gaining Insights into Mutation Frequencies, Protein Stability and Prospective Effect on Pathogenicity
Akshay Uttarkar, Vidya Niranjan*, Shivam Pandit and Srividya Subash
DOI: 10.2174/2666796702666210118155636
View Abstract
Knowledge Evaluation of Hand Hygiene and Infectious Diseases in Lebanon
Jana Taleb, Najwa Sankari, Maya Alaa Dine Kassem, Rabih Roufayel and Seifedine Kadry*
DOI: 10.2174/2666796702666210114105558
View Abstract
A Recent Update on Therapeutics to Treat Emerging n-COVID 19: A Review
Sumel Ashique, Navjot K. Sandhu*, Sk. Niyamul Haque and Kartick Koley
DOI: 10.2174/2666796701999201204123259
View Abstract
Angiotensin Converting Enzyme-2: A Doorway for SARS-CoV-2
Vikas Pandey, Indu Lata Kanwar, Tanweer Haider, Vishal Gour, Monika Vishwakarma, Avijit Kumar Bakshi, Ravishankar Yadav and Vandana Soni*
DOI: 10.2174/2666796702666210222110044
View Abstract
Virtual Screening of the Flavonoids Compounds with the SARS-CoV-2 3C-like Protease as the Lead Compounds for the COVID-19
Gabriella Patricia Adisurja and Arli Aditya Parkesit*
DOI: 10.2174/2666796702666210222105547
View Abstract
Immunity Modulators, Repurposed Drugs and Candidate Vaccines for COVID-19: A Review
Rashmy Nair, Ravindra Singh Rao, Placheril Joseph John and Poonam Khandelwal*
DOI: 10.2174/2666796702999210112203139
View Abstract
Neurovirulence of SARS CoV2: From Clinical Data to Preclinical Neuropsychological Exploration
Youness Kadil * and Houda Filali
DOI: 10.2174/2666796702666210202124417
View Abstract
The Genomes of SARS-CoV-2 and Related Coronaviruses: Are Accessory Proteins Key for Pathogenesis?
Saikat Samanta and Rudra Prasad Saha*
DOI: 10.2174/2666796701999201209143320
View Abstract
Abstracts Ahead of Print
Graphene versus coronavirus: A study of the graphene properties that can help to combat coronavirus
T. Guerra*, I. O. Assis and A. B. Guerra
DOI: 10.2174/2666796702666210329143841
View Abstract
Detection of Viruses: insides of antibody-antigen interactions and Multifunctional Lab-On-particle for SARS CoV-2 detection
Martin Amé, Esraa Samy Abu Serea, Ahmed Esmail Shalan and A. Guillermo Bracamonte*
DOI: 10.2174/2666796702666210329142505
View Abstract
Lipid lowering natural products targeting hPCSK9 may prevent the severity of COVID-19 infection
Ajoy Basak*, Jaishree Vaijanathappa and Sarmistha Basak
DOI: 10.2174/2666796702666210329141042
View Abstract
Administration of exogenous surfactant and cytosolic phospholipase A2α inhibitors may help COVID-19 infected patients with chronic disease
Mohammed Abdalla Hussein*
DOI: 10.2174/2666796702666210311123323
View Abstract
New Perspectives for SARS-CoV-2 Rapid Detection
Latifa Khattabi*, Mustapha Mounir Bouhenna and Feriel Sellam
DOI: 10.2174/2666796702666210308114737
View Abstract
Transmission, Prevention and Therapeutic Strategies for COVID-19: Updates and Challenges
Habibur Rahman*
DOI: 10.2174/2666796702666210308114216
View Abstract
Effect of miRNAs, proinflammatory cytokines and ACE2 in COVID-19 pathophysiology
Hari Om Singh*, Kamini Jakhar, Vijay Nema, Asha Krishnaraj and Ranjana Choudhari
DOI: 10.2174/2666796702666210303114330
View Abstract
Economic Fluctuations- the Aftermath of COVID 19 Pandemic
Saishiv Adithya and Koyeli Girigoswami*
DOI: 10.2174/2666796702666210301124727
View Abstract
Therapeutically Important Natural Products and their Derivatives as a Target for Treatment of COVID-19 (SARSCoV2)
Subhash and Ashu Chaudhary*
DOI: 10.2174/2666796702666210301124357
View Abstract
SARS-CoV-2: Molecular biology and therapeutic target.
Vivek Pandey, Ankita Pathak, Mohammad Shahar Yar and Yuba Raj Pokharel*
DOI: 10.2174/2666796702666210225103821
View Abstract
Published Contents
Editor's Choice
Symptoms, Transmission, Prevention and Treatment of Pandemic Corona Virus: A Review
, 2021; 2(2): 151 - 158Tinsae Kebede, Dharmendra Kumar* and Pramod Kumar Sharma
DOI: 10.2174/2666796701999200713191436
Vitamin D3 Deficiency and COVID-19
, 2021; 2(1): 2 - 3Olen R. Brown* and Martin R. Hullender
DOI: 10.2174/2666796701999200914112352
Potential Drug Options for Treatment of COVID-19: A Review
, 2020; 1(1): 42 - 48Tinsae Kebede, Dharmendra Kumar* and Pramod Kumar Sharma
DOI: 10.2174/2666796701999200701131604
Open Access Articles
Synthetic Lung Surfactant Treatment for COVID-19 Pneumonia
, 2021; 2(1): 8 - 10Frans J. Walther* and Alan J. Waring
Dealing with COVID-19: Lessons Learned from the Italian Experience
, 2021; 2(1): 27 - 29Silvana Mirella Aliberti*, Francesco De Caro, Giovanni Boccia, Rosario Caruso and Mario Capunzo
Most Cited Articles
Most Accessed Articles
The COVID-19 and Ageism in Social Media
, 2020; 1(1): 7-8.Yadollah Abolfathi Momtaz*
DOI: 10.2174/2666796701999200621203144
A Note on the Potential BCG Vaccination – COVID-19 Molecular Link
, 2020; 1(1): 4-6.Alex Y. Strongin, Alex Sloutsky and Piotr Cieplak*
DOI: 10.2174/2666796701999200629003417
Amantadine Might be Used as a Drug for SARS-Cov-2 Treatment?
, 2021; 2(1): 6-7.Zeynep Gunes Ozunal and Sevki Sahin*
DOI: 10.2174/2666796701999200713192912
Activity of Some Novel Chalcone Substituted 9-anilinoacridines against Coronavirus (COVID-19): A Computational Approach
, 2020; 1(1): 13-22.Rajagopal Kalirajan*
DOI: 10.2174/2666796701999200625210746
Potential Immunotherapy against SARS-CoV-2: Strategy and Status
, 2020; 1(1): 23-31.Abid H. Banday*, Shameem A. Shah and Sheikh J. Ajaz
DOI: 10.2174/2666796701999200625212040
nCovid-19 in 2020: From Despair to Hope
, 2020; 1(1): 9-12.Ravi Varala* and Haribabu Bollikolla
DOI: 10.2174/2666796701999200621202839
Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach
, 2020; 1(1): 73-81.Sibi Raj, Vaishali Chandel, Brijesh Rathi and Dhruv Kumar*
DOI: 10.2174/2666796701999200617155013
Dealing with COVID-19: Lessons Learned from the Italian Experience
, 2021; 2(1): 27-29.Silvana Mirella Aliberti*, Francesco De Caro, Giovanni Boccia, Rosario Caruso and Mario Capunzo
DOI: 10.2174/2666796701999200908094136
Vitamin D3 Deficiency and COVID-19
, 2021; 2(1): 2-3.Olen R. Brown* and Martin R. Hullender
DOI: 10.2174/2666796701999200914112352
COVID-19: Morphology, Characteristics, Symptoms, Prevention, Clinical Diagnosis and Current Scenario
, 2020; 1(1): 82-89.Tansukh Barupal, Praveen Kumar Tak and Mukesh Meena*
DOI: 10.2174/2666796701999200617161348
Synthetic Lung Surfactant Treatment for COVID-19 Pneumonia
, 2021; 2(1): 8-10.Frans J. Walther* and Alan J. Waring
DOI: 10.2174/2666796701999201014160428
Virtual Screening of Potential Therapeutic Inhibitors Against Spike, Helicase, and Polymerase of SARS-CoV-2 (COVID-19)
, 2021; 2(1): 89-105.Ayesha Tazeen, Farah Deeba, Aftab Alam, Rafat Ali, Romana Ishrat, Anwar Ahmed, Sher Ali and Shama Parveen*
DOI: 10.2174/2666796701999200826114306
Study of the Relationships between COVID-19, Associated Diseases, and Vitamins
, 2021; 2(1): 118-130.Alice Barros Câmara* and Igor Augusto Brandão
DOI: 10.2174/2666796701999200713193408
The Effects of Coronavirus (COVID-19) on the Psychological Health of Indian Poultry Farmers
, 2021; 2(2): 131-132.Gaurav Dhiman*
DOI: 10.2174/2666796701999200617160755
Editor-in-Chief
Jean-Marc Sabatier
Institute of NeuroPhysiopathology
Marseille, Cedex
(France)
Biography
Institute of NeuroPhysiopathology
Marseille, Cedex
Biography
Biography of Jean-Marc Sabatier
Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry.
Honorary Senior Advisors
Ferid Murad
(USA)
Atta-ur-Rahman, FRS
(UK)
About the Journal
For Authors
For Librarians & Readers
Webmaster Contact: info@benthamscience.net